Clinical Trials Directory

Trials / Unknown

UnknownNCT02777034

Laparoscopy Combined With Enhanced Recovery Pathway

Short-Term Outcomes of Laparoscopy Combined With Enhanced Recovery Pathway After Ileocolon Resection for Crohn's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Sir Run Run Shaw Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Laparoscopy combined with an enhanced recovery pathway versus laparoscopy combined with a traditional recovery pathway after ileocolon resection for Crohn's Disease.

Detailed description

Thirty patients with CD of ileocolon will be randomly assigned to two groups.One group is ERP group which include no bowel preparation nor fasting, no abdominal drains, early removal of urinary catheter, early solid dietary intake and mobilization and restrictive fluid management.In the end,we can compare the time to first flatus、time to first flatus 、postoperative length of stay postoperative hospital expense、complication grade readmission within 30 days of discharge between the two groups.

Conditions

Interventions

TypeNameDescription
OTHERERPreoperative protocols:Multidisciplinary patient information、no bowel preparation、no fasting(drink 10% glucose 1000 at 21:30 night before the surgery). Intraoperative protocols:Laparoscopic standardized technique、fluid restriction (max 500 ml/h)、no abdominal drains. Postoperative protocols:no nasogastric tube、early solid dietary intake and mobilization、urinary catheter removal on postoperative day 1、restrictive fluid management(\<2000ml/d).
OTHERURPreoperative protocols:Patient information、Mechanical bowel preparation、Fasting since midnight before operation. Intraoperative protocols:Laparoscopic standardized technique、fluid overload (over 500 ml/h) 、place abdominal drains. Postoperative protocols:no nasogastric tube、mobilization from postoperative day 1、fluids and solids intake after first passage of stool、Urinary catheter removal on postoperative day 2/3、no restrictive fluid management(\>2000ml/d).

Timeline

Start date
2016-05-01
Primary completion
2017-05-01
Completion
2017-12-01
First posted
2016-05-19
Last updated
2016-05-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02777034. Inclusion in this directory is not an endorsement.